Bittium Oyj (0JG5)
London Exchange · UK · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 34.45 |
|---|---|
| 52-week range | 13.09 – 43.05 |
| Return, 1 month / 3 months | −10.2% / +22.7% |
| Return, 1 year / 3 years | +144.2% / +748.6% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 41 |
| Volatility (1 year) | 67.9% |
| Worst drawdown (1 year) | -40.1% |
| Average daily value traded | 0.21M EUR |
| Dividend yield | 0.9% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Bittium Oyj is a Finnish technology company based in Oulu that develops secure communications products and services. It supplies tactical communications systems, rugged handheld and vehicle-mounted radios, and secure mobile devices to defence forces, government agencies and other organisations with demanding security needs. The company also makes medical technology products, including cardiac monitoring and remote patient monitoring devices, for healthcare providers and hospitals. Its customers are mainly in Finland and other European countries, with some international defence and healthcare business.
Bittium Oyj trades under the code 0JG5 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 7 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Bittium Oyj (0JG5) trades on the London Exchange in UK. It last closed at EUR 34.45 on 22 October 2026.
Its price-based Market X-Ray is 48 out of 100 (a weak price profile), ranking 2,162 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 144.2% and over the last three months it rose 22.7%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 57 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 0.4% | ||
| From 52-week high | -19.0% | ||
| Momentum | 74 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 22.7% | ||
| 6-month return | -7.0% | ||
| 12-month return, skipping the last month | 171.9% | ||
| Stability (higher is calmer) | 23 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 67.9% | ||
| Worst drawdown, 1 year (smaller is calmer) | -40.1% | ||
| Liquidity | 37 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.21M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 43 · Weak | Dividend is small or irregular. | |
| Dividend yield | 0.9% | ||
| Years with dividends | 5 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
- Income: Dividend is small or irregular.
Returns
| 1 week | +0.5% |
|---|---|
| 1 month | −10.2% |
| 3 months | +22.7% |
| 6 months | −7.0% |
| 1 year | +144.2% |
| 3 years | +748.6% |
| 5 years | – |
Signals
| 50-day / 200-day average | 36.96 / 34.33 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 1.26 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 10 Aug 2026 | EUR 0.1500 |
| 23 Apr 2026 | EUR 0.1500 |
| 8 May 2025 | EUR 0.1000 |
| 21 Oct 2024 | EUR 0.0300 |
| 11 Apr 2024 | EUR 0.0300 |
| 13 Apr 2023 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.